SCHEMBL185434

SCHEMBL185434

O=CCc1ccc(Nc2ccc(Br)cc2C(F)(F)F)cn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.35
CNR2 P34972 1/20 0.34
EGFR P00533 1/20 0.34
KDR P35968 1/20 0.34
MPO P05164 1/20 0.33
S1PR4 O95977 1/20 0.32
TAS2R14 Q9NYV8 1/20 0.32
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
KDM1A O60341 2/20 0.32
CDK1 P06493 1/20 0.31
CDK4 P11802 1/20 0.31
MAPK3 P27361 1/20 0.31
KIT P10721 1/20 0.31
FLT3 P36888 1/20 0.31
PTK2 Q05397 2/20 0.31
HCAR1 Q9BXC0 1/20 0.31
CHEK1 O14757 1/20 0.31
KCNQ3 O43525 1/20 0.30
KCNQ2 O43526 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14957374 0.88 CNR2 (0.36) CNR2MPOKITFLT3KCNQ3
SCHEMBL185856 0.86 RAB9A (0.40) CNR2KCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL186066 0.84 OPRM1 (0.37) OPRM1CNR2EGFRKDRMPO
SCHEMBL14957673 0.83 ALDH1A1 (0.41) EGFR
SCHEMBL2807621 0.80 CNR2 (0.40) OPRM1CNR2EGFRKDRMPO
Trifluoroacetic Acid SCHEMBL2807624 0.80 MPO (0.38) OPRM1CNR2EGFRKDRMPO
SCHEMBL27853681 0.79 OPRM1 (0.39) OPRM1CNR2EGFRKDRMPO
SCHEMBL184811 0.77 OPRM1 (0.44) OPRM1CNR2MPOS1PR4KDM1A
SCHEMBL27870360 0.77 OPRM1 (0.36) OPRM1CNR2EGFRKDRMPO
SCHEMBL2808542 0.76 CNR2 (0.41) OPRM1CNR2EGFRKDRMPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed